Striatal interaction among dopamine, glutamate and ascorbate

Neuropharmacology

Volumn 63, Issue 8, 2012, Pages 1308-1314

  Morales, Ingrid ^a,c   Fuentes, Angel ^a   Ballaz, Santiago ^b,c   Obeso, Jose A ^b,c   Rodriguez, Manuel ^a,c  

^a UNIVERSIDAD DE LA LAGUNA   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

Author keywords

Ascorbic acid; Dopamine; Glutamate; Parkinson's disease; Striatum

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; ASCORBIC ACID; DOPAMINE; GLUTAMIC ACID; GLUTAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; MALE; MICRODIALYSIS; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; RAT; SUBSTANTIA NIGRA;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; BASAL GANGLIA DISEASES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOPAMINE; DOPAMINE AGENTS; DOPAMINE ANTAGONISTS; ELECTROCHEMISTRY; FLUOROMETRY; GLUTAMIC ACID; HALOPERIDOL; LEVODOPA; MALE; MICRODIALYSIS; NEOSTRIATUM; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84867515615     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2012.08.007     Document Type: Article

References (90)

1. D. Afonso, M.A. Castellanos, and M. Rodriguez Determination of monoamines and indoles in amniotic fluid by high-performance liquid chromatography- electrochemical detection J. Chromatogr. 528 1990 101 109
2. E. Aizenman, W.F. White, R.H. Loring, and P.A. Rosenberg A 3,4-dihydroxyphenylalanine oxidation product is a non-N-methyl-D-aspartate glutamatergic agonist in rat cortical neurons Neurosci. Lett. 116 1990 168 171
3. Andre, V.M., Cepeda, C., Levine, M.S. Dopamine and glutamate in Huntington's disease: a balancing act. CNS Neurosci. Ther. 16, 163-178.
4. R. Araneda, and G. Bustos Modulation of dendritic release of dopamine by N-methyl-D-aspartate receptors in rat substantia nigra J. Neurochem. 52 1989 962 970
5. A. Araque, N. Li, R.T. Doyle, and P.G. Haydon SNARE protein-dependent glutamate release from astrocytes J. Neurosci. 20 2000 666 673
6. A. Araque, V. Parpura, R.P. Sanzgiri, and P.G. Haydon Tripartite synapses: glia, the unacknowledged partner Trends Neurosci. 22 1999 208 215
7. S. Arbilla, and S.Z. Langer Stereoselectivity of presynaptic autoreceptors modulating dopamine release Eur. J. Pharmacol. 76 1981 345 351
8. A. Basse-Tomusk, and G.V. Rebec Regional distribution of ascorbate and 3,4-dihydroxyphenylacetic acid (DOPAC) in rat striatum Brain Res. 538 1991 29 35
9. M.F. Beal, N.W. Kowall, D.W. Ellison, M.F. Mazurek, K.J. Swartz, and J.B. Martin Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid Nature 321 1986 168 171
10. M.J. Beckstead, D.K. Grandy, K. Wickman, and J.T. Williams Vesicular dopamine release elicits an inhibitory postsynaptic current in midbrain dopamine neurons Neuron 42 2004 939 946
11. L.M. Borland, and A.C. Michael Voltammetric study of the control of striatal dopamine release by glutamate J. Neurochem. 91 2004 220 229
12. R.K. Bruton, J. Ge, and N.M. Barnes Group I mGlu receptor modulation of dopamine release in the rat striatum in vivo Eur. J. Pharmacol. 369 1999 175 181
13. P. Calabresi, N.B. Mercuri, and G. Bernardi Chemical modulation of synaptic transmission in the striatum Prog. Brain Res. 99 1993 299 308
14. J. Cammack, B. Ghasemzadeh, and R.N. Adams The pharmacological profile of glutamate-evoked ascorbic acid efflux measured by in vivo electrochemistry Brain Res. 565 1991 17 22
15. M. Carlsson, and A. Carlsson Interactions between glutamatergic and monoaminergic systems within the basal ganglia - implications for schizophrenia and Parkinson's disease Trends Neurosci. 13 1990 272 276
16. J.T. Coyle, and P. Puttfarcken Oxidative stress, glutamate, and neurodegenerative disorders Science 262 1993 689 695
17. J.T. Coyle, and R. Schwarcz Lesion of striatal neurones with kainic acid provides a model for Huntington's chorea Nature 263 1976 244 246
18. S.J. Cragg, and M.E. Rice DAncing past the DAT at a DA synapse Trends Neurosci. 27 2004 270 277
19. I. Cruz-Muros, D. Afonso-Oramas, P. Abreu, M.M. Perez-Delgado, M. Rodriguez, and T. Gonzalez-Hernandez Aging effects on the dopamine transporter expression and compensatory mechanisms Neurobiol. Aging 30 2009 973 986
20. P. Damier, E.C. Hirsch, Y. Agid, and A.M. Graybiel The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease Brain 122 8 1999 1437 1448
21. S. Di Loreto, T. Florio, and E. Scarnati Evidence that non-NMDA receptors are involved in the excitatory pathway from the pedunculopontine region to nigrostriatal dopaminergic neurons Exp. Brain Res. 89 1992 79 86
22. M.J. During, K.M. Ryder, and D.D. Spencer Hippocampal GABA transporter function in temporal-lobe epilepsy Nature 376 1995 174 177
23. A.J. Eshleman, R.A. Henningsen, K.A. Neve, and A. Janowsky Release of dopamine via the human transporter Mol. Pharmacol. 45 1994 312 316
24. B.H. Falkenburger, K.L. Barstow, and I.M. Mintz Dendrodendritic inhibition through reversal of dopamine transport Science 293 2001 2465 2470
25. R.S. Fisher, M.S. Levine, D.R. Sibley, and M.A. Ariano D2 dopamine receptor protein location: golgi impregnation-gold toned and ultrastructural analysis of the rat neostriatum J. Neurosci. Res. 38 1994 551 564
26. J. Flores-Hernandez, E. Galarraga, and J. Bargas Dopamine selects glutamatergic inputs to neostriatal neurons Synapse 25 1997 185 195
27. M. Frotscher, U. Rinne, R. Hassler, and A. Wagner Termination of cortical afferents on identified neurons in the caudate nucleus of the cat. A combined golgi-EM degeneration study Exp. Brain Res. 41 1981 329 337
28. M. Garcia-Munoz, S.J. Young, and P.M. Groves Terminal excitability of the corticostriatal pathway. I. Regulation by dopamine receptor stimulation Brain Res. 551 1991 195 206
29. J. Garcia Dopico, J. Perdomo Diaz, T.J. Alonso, T. Gonzalez Hernandez, R. Castro Fuentes, and M. Rodriguez Diaz Extracellular taurine in the substantia nigra: taurine-glutamate interaction J. Neurosci. Res. 76 2004 528 538
30. M.C. Garrett, and P. Soares-da-Silva Role of type A and B monoamine oxidase on the formation of 3,4-dihydroxyphenylacetic acid (DOPAC) in tissues from the brain of the rat Neuropharmacology 29 1990 875 879
31. L.B. Geffen, T.M. Jessell, A.C. Cuello, and L.L. Iversen Release of dopamine from dendrites in rat substantia nigra Nature 260 1976 258 260
32. B. Ghasemzadeh, J. Cammack, and R.N. Adams Dynamic changes in extracellular fluid ascorbic acid monitored by in vivo electrochemistry Brain Res. 547 1991 162 166
33. M.Y. Globus, M.D. Ginsberg, W.D. Dietrich, R. Busto, and P. Scheinberg Substantia nigra lesion protects against ischemic damage in the striatum Neurosci. Lett. 80 1987 251 256
34. P. Guidetti, G.P. Bates, R.K. Graham, M.R. Hayden, B.R. Leavitt, M.E. MacDonald, E.J. Slow, V.C. Wheeler, B. Woodman, and R. Schwarcz Elevated brain 3-hydroxykynurenine and quinolinate levels in Huntington disease mice Neurobiol. Dis. 23 2006 190 197
35. K.S. Hsu, C.C. Huang, C.H. Yang, and P.W. Gean Presynaptic D2 dopaminergic receptors mediate inhibition of excitatory synaptic transmission in rat neostriatum Brain Res. 690 1995 264 268
36. S.L. Ingram, B.M. Prasad, and S.G. Amara Dopamine transporter-mediated conductances increase excitability of midbrain dopamine neurons Nat. Neurosci. 5 2002 971 978
37. Y. Iribe, K. Moore, K.C. Pang, and J.M. Tepper Subthalamic stimulation-induced synaptic responses in substantia nigra pars compacta dopaminergic neurons in vitro J. Neurophysiol. 82 1999 925 933
38. D. Jabaudon, K. Shimamoto, Y. Yasuda-Kamatani, M. Scanziani, B.H. Gahwiler, and U. Gerber Inhibition of uptake unmasks rapid extracellular turnover of glutamate of nonvesicular origin Proc. Natl. Acad. Sci. U. S. A. 96 1999 8733 8738
39. E.H. Jaffe, A. Marty, A. Schulte, and R.H. Chow Extrasynaptic vesicular transmitter release from the somata of substantia nigra neurons in rat midbrain slices J. Neurosci. 18 1998 3548 3553
40. P. Jenner, and C.W. Olanow Understanding cell death in Parkinson's disease Ann. Neurol. 44 1998 S72 S84
41. F. Karoum, S.J. Chrapusta, R. Brinjak, A. Hitri, and R.J. Wyatt Regional effects of amphetamine, cocaine, nomifensine and GBR 12909 on the dynamics of dopamine release and metabolism in the rat brain Br. J. Pharmacol. 113 1994 1391 1399
42. N.V. Kulagina, M.J. Zigmond, and A.C. Michael Glutamate regulates the spontaneous and evoked release of dopamine in the rat striatum Neuroscience 102 2001 121 128
43. Y.J. Lai, E.Y. Shen, and W.H. Pan Effects of ascorbate in microdialysis perfusion medium on the extracellular basal concentration of glutamate in rat's striatum Neurosci. Lett. 279 2000 145 148
44. B. Lavoie, and A. Parent Pedunculopontine nucleus in the squirrel monkey: distribution of cholinergic and monoaminergic neurons in the mesopontine tegmentum with evidence for the presence of glutamate in cholinergic neurons J. Comp. Neurol. 344 1994 190 209
45. M. Marti, S. Sbrenna, K. Fuxe, C. Bianchi, L. Beani, and M. Morari Increased responsivity of glutamate release from the substantia nigra pars reticulata to striatal NMDA receptor blockade in a model of Parkinson's disease. A dual probe microdialysis study in hemiparkinsonian rats Eur. J. Neurosci. 12 2000 1848 1850
46. G. Maura, A. Giardi, and M. Raiteri Release-regulating D-2 dopamine receptors are located on striatal glutamatergic nerve terminals J. Pharmacol. Exp. Ther. 247 1988 680 684
47. N. Mercuri, G. Bernardi, P. Calabresi, A. Cotugno, G. Levi, and P. Stanzione Dopamine decreases cell excitability in rat striatal neurons by pre- and postsynaptic mechanisms Brain Res. 358 1985 110 121
48. C.K. Meshul, N. Emre, C.M. Nakamura, C. Allen, M.K. Donohue, and J.F. Buckman Time-dependent changes in striatal glutamate synapses following a 6-hydroxydopamine lesion Neuroscience 88 1999 1 16
49. P.R. Mitchell, and N.S. Doggett Modulation of striatal [3H]-glutamic acid release by dopaminergic drugs Life Sci. 26 1980 2073 2081
50. I. Morales, A. Fuentes, T. Gonzalez-Hernandez, and M. Rodriguez Osmosensitive response of glutamate in the substantia nigra Exp. Neurol. 220 2009 335 340
51. J. Moss, and J.P. Bolam A dopaminergic axon lattice in the striatum and its relationship with cortical and thalamic terminals J. Neurosci. 28 2008 11221 11230
52. H.J. Nauta, and M. Cole Efferent projections of the subthalamic nucleus: an autoradiographic study in monkey and cat J. Comp. Neurol. 180 1978 1 16
53. T.A. Newcomer, A.M. Palmer, P.A. Rosenberg, and E. Aizenman Nonenzymatic conversion of 3,4-dihydroxyphenylalanine to 2,4,5-trihydroxyphenylalanine and 2,4,5-trihydroxyphenylalanine quinone in physiological solutions J. Neurochem. 61 1993 911 920
54. K. Niijima, and M. Yoshida Activation of mesencephalic dopamine neurons by chemical stimulation of the nucleus tegmenti pedunculopontinus pars compacta Brain Res. 451 1988 163 171
55. R.D. O'Neill, and M. Fillenz Circadian changes in extracellular ascorbate in rat cortex, accumbens, striatum and hippocampus: correlations with motor activity Neurosci. Lett. 60 1985 331 336
56. R.D. O'Neill, M. Fillenz, L. Sundstrom, and J.N. Rawlins Voltammetrically monitored brain ascorbate as an index of excitatory amino acid release in the unrestrained rat Neurosci. Lett. 52 1984 227 233
57. J.A. Obeso, M.C. Rodriguez-Oroz, M. Rodriguez, J.L. Lanciego, J. Artieda, N. Gonzalo, and C.W. Olanow Pathophysiology of the basal ganglia in Parkinson's disease Trends Neurosci. 23 2000 S8 S19
58. T.P. Obrenovitch, and D.A. Richards Extracellular neurotransmitter changes in cerebral ischaemia Cerebrovasc. Brain Metab. Rev. 7 1995 1 54
59. C.W. Olanow, and W.G. Tatton Etiology and pathogenesis of Parkinson's disease Annu. Rev. Neurosci. 22 1999 123 144
60. G. Page, M. Peeters, M. Najimi, J.M. Maloteaux, and E. Hermans Modulation of the neuronal dopamine transporter activity by the metabotropic glutamate receptor mGluR5 in rat striatal synaptosomes through phosphorylation mediated processes J. Neurochem. 76 2001 1282 1290
61. A. Parent, and L.N. Hazrati Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry Brain Res. Brain Res. Rev. 20 1995 128 154
62. L. Pasti, A. Volterra, T. Pozzan, and G. Carmignoto Intracellular calcium oscillations in astrocytes: a highly plastic, bidirectional form of communication between neurons and astrocytes in situ J. Neurosci. 17 1997 7817 7830
63. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates 1986 Academic Press Inc. Orlando, Florida, USA
64. R.C. Pierce, and G.V. Rebec Intraneostriatal administration of glutamate antagonists increases behavioral activation and decreases neostriatal ascorbate via nondopaminergic mechanisms J. Neurosci. 13 1993 4272 4280
65. G.V. Rebec, S.J. Barton, and M.D. Ennis Dysregulation of ascorbate release in the striatum of behaving mice expressing the Huntington's disease gene J. Neurosci. 22 2002 RC202
66. G.V. Rebec, and Z. Wang Behavioral activation in rats requires endogenous ascorbate release in striatum J. Neurosci. 21 2001 668 675
67. G.V. Rebec, S.R. Witowski, M.I. Sandstrom, R.D. Rostand, and R.T. Kennedy Extracellular ascorbate modulates cortically evoked glutamate dynamics in rat striatum Neurosci. Lett. 378 2005 166 170
68. A. Rescigno, A.C. Rinaldi, and E. Sanjust Some aspects of tyrosine secondary metabolism Biochem. Pharmacol. 56 1998 1089 1096
69. M.E. Rice, and S.J. Cragg Dopamine spillover after quantal release: rethinking dopamine transmission in the nigrostriatal pathway Brain Res. Rev. 58 2008 303 313
70. E. Rinvik, and O.P. Ottersen Terminals of subthalamonigral fibres are enriched with glutamate-like immunoreactivity: an electron microscopic, immunogold analysis in the cat J. Chem. Neuroanat. 6 1993 19 30
71. M. Rodriguez Diaz, T.J. Alonso, J. Perdomo Diaz, T. Gonzalez Hernandez, R. Castro Fuentes, M. Sabate, and J. Garcia Dopico Glial regulation of nonsynaptic extracellular glutamate in the substantia nigra Glia 49 2005 134 142
72. M. Rodriguez, P. Barroso-Chinea, P. Abdala, J. Obeso, and T. Gonzalez-Hernandez Dopamine cell degeneration induced by intraventricular administration of 6-hydroxydopamine in the rat: similarities with cell loss in Parkinson's disease Exp. Neurol. 169 2001 163 181
73. M. Rodriguez, and R. Castro Apomorphine lowers dopamine synthesis for up to 48 h: implications for drug sensitization Neuroreport 2 1991 365 368
74. M. Rodriguez, I. Morales, I. Gomez, S. Gonzalez, T. Gonzalez-Hernandez, and J.L. Gonzalez-Mora Heterogeneous dopamine neurochemistry in the striatum: the fountain-drain matrix J. Pharmacol. Exp. Ther. 319 2006 1 13
75. M. Rodriguez, E. Pereda, J. Gonzalez, P. Abdala, and J.A. Obeso How is firing activity of substantia nigra cells regulated? Relevance of pattern-code in the basal ganglia Synapse 49 2003 216 225
76. M.C. Rodriguez, J.A. Obeso, and C.W. Olanow Subthalamic nucleus-mediated excitotoxicity in Parkinson's disease: a target for neuroprotection Ann. Neurol. 44 1998 S175 S188
77. S. Roffler-Tarlov, D.F. Sharman, and P. Tegerdine 3,4- dihydroxyphenylacetic acid and 4-hydroxy-3-methoxyphenylacetic acid in the mouse striatum: a reflection of intra- and extra-neuronal metabolism of dopamine? Br. J. Pharmacol. 42 1971 343 351
78. P.A. Rosenberg, R. Loring, Y. Xie, V. Zaleskas, and E. Aizenman 2,4,5-Trihydroxyphenylalanine in solution forms a non-N-methyl-D-aspartate glutamatergic agonist and neurotoxin Proc. Natl. Acad. Sci. U. S. A. 88 1991 4865 4869
79. G.F. Rowlands, and P.J. Roberts Activation of dopamine receptors inhibits calcium-dependent glutamate release from cortico-striatal terminals in vitro Eur. J. Pharmacol. 62 1980 241 242
80. M.I. Sandstrom, and G.V. Rebec Extracellular ascorbate modulates glutamate dynamics: role of behavioral activation BMC Neurosci. 8 2007 32
81. E. Scarnati, A. Proia, E. Campana, and C. Pacitti A microiontophoretic study on the nature of the putative synaptic neurotransmitter involved in the pedunculopontine-substantia nigra pars compacta excitatory pathway of the rat Exp. Brain Res. 62 1986 470 478
82. Y. Smith, M.D. Bevan, E. Shink, and J.P. Bolam Microcircuitry of the direct and indirect pathways of the basal ganglia Neuroscience 86 1998 353 387
83. P. Somogyi, J.P. Bolam, and A.D. Smith Monosynaptic cortical input and local axon collaterals of identified striatonigral neurons. A light and electron microscopic study using the golgi-peroxidase transport-degeneration procedure J. Comp. Neurol. 195 1981 567 584
84. D.J. Surmeier, J. Ding, M. Day, Z. Wang, and W. Shen D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons Trends Neurosci. 30 2007 228 235
85. A. Verma, and B. Moghaddam Regulation of striatal dopamine release by metabotropic glutamate receptors Synapse 28 1998 220 226
86. A.K. Wagner, J.E. Sokoloski, D. Ren, X. Chen, A.S. Khan, R.D. Zafonte, A.C. Michael, and C.E. Dixon Controlled cortical impact injury affects dopaminergic transmission in the rat striatum J. Neurochem. 95 2005 457 465
87. L.J. Wallace, and J.S. Traeger Dopac distribution and regulation in striatal dopaminergic varicosities and extracellular space Synapse 66 2012 160 173
88. B.H. Westerink, F.J. Bosker, and E. Wirix Formation and metabolism of dopamine in nine areas of the rat brain: modifications by haloperidol J. Neurochem. 42 1984 1321 1327
89. U. Wullner, C.M. Testa, M.V. Catania, A.B. Young, and J.B. Penney Jr. Glutamate receptors in striatum and substantia nigra: effects of medial forebrain bundle lesions Brain Res. 645 1994 98 102
90. T. Zetterstrom, T. Sharp, A.K. Collin, and U. Ungerstedt In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs; implications for the origin of extracellular DOPAC Eur. J. Pharmacol. 148 1988 327 334